---
category: disclosure
circular_id: 0b37bd8952ea18da
date: '2025-11-14'
description: BSE clarifications from Thyrocare Technologies Ltd and Hemisphere Properties
  India Limited regarding significant movement in share volumes.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={4BEAA02D-9228-4FC4-A719-624C6DB54FEC}&noticeno=20251114-16&dt=11/14/2025&icount=16&totcount=50&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine surveillance clarifications with no new material information
  disclosed by companies; both confirmed movement is market-driven with no undisclosed
  price sensitive information
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251114-16&attachedId=7fb5974b-d9e2-4ce4-bd66-6a5d83eab376
processing:
  attempts: 1
  content_hash: ad463bc14af056f2
  processed_at: '2025-11-14T15:35:21.178811'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-14T12:47:37+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={4BEAA02D-9228-4FC4-A719-624C6DB54FEC}&noticeno=20251114-16&dt=11/14/2025&icount=16&totcount=50&flag=0
severity: low
source: bse
stocks:
- THYROCARE
- HEMIPROP
tags:
- clarification
- price-movement
- regulation-30
- surveillance
title: Clarifications received from the companies
---

## Summary

BSE sought clarifications from Thyrocare Technologies Limited (Scrip Code: 539871) and Hemisphere Properties India Limited (Scrip Code: 543242, Symbol: HEMIPROP) regarding significant increases in trading volumes. Both companies confirmed they have no pending material information to disclose and that the volume increases are purely market-driven, with management not connected to the price/volume movements.

## Key Points

- Thyrocare Technologies Ltd responded to BSE's November 14, 2025 clarification request (Ref: L/SURV/ONL/PV/AA/2025-2026/678)
- Hemisphere Properties India Limited responded to BSE and NSE clarification requests dated November 13-14, 2025
- Both companies confirmed all material information has been disclosed in accordance with Regulation 30 of SEBI LODR 2015
- Companies stated they are unaware of specific reasons for volume increases
- Volume/price movements attributed to market forces, not management actions
- No undisclosed price sensitive information exists

## Regulatory Changes

No regulatory changes announced.

## Compliance Requirements

- Companies reaffirmed commitment to timely disclosures under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Disclosures made in accordance with respective Materiality Policies
- Both companies confirmed adherence to Board-approved disclosure guidelines

## Important Dates

- **November 13, 2025**: BSE/NSE sent clarification request to Hemisphere Properties
- **November 14, 2025**: BSE sent clarification request to Thyrocare Technologies
- **November 14, 2025**: Both companies submitted clarification responses

## Impact Assessment

**Market Impact**: Low - These are standard surveillance clarifications with no new material information disclosed. The responses indicate normal market activity without corporate actions or undisclosed developments.

**Investor Impact**: Minimal - Provides transparency that volume spikes are market-driven rather than due to pending corporate announcements. No action required from investors.

**Operational Impact**: None - No changes to company operations or compliance requirements.

## Company Details

**Thyrocare Technologies Limited**
- CIN: L85110MH2000PLC123882
- BSE Scrip Code: 539871
- Registered Office: D-37/1, TTC MIDC, Turbhe, Navi Mumbai-400703
- Response signed by: Brijesh Kumar, Company Secretary and Compliance Officer

**Hemisphere Properties India Limited**
- CIN: L70101DL2005GOI132162
- BSE Scrip Code: 543242
- NSE Symbol: HEMIPROP
- Registered Office: Room No. I7, C-Wing, Nirman Bhawan, Maulana Azad Road, New Delhi 110001
- Government of India Enterprise